News Release

Norfolk, VA, October 30, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming BIOEurope® 2019 – 25th Annual International Partnering Conference being held November 11-13, 2019 in Hamburg, Germany. At the conference, the ReAlta team will meet with pharmaceutical companies to discuss its PIC1 technology platform and co-development opportunities, as well as institutional investors and industry partners.

About BIO-Europe^® — BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high-profile exhibition, and private, prescheduled one-on-one meetings. The BIO-Europe 2019 partnering event is expected to draw over 4,000 industry attendees for three days of high-level networking, representing upwards of 2,300 companies from over 50 countries.

ABOUT REALTA — ReAlta Life Sciences, Inc. is an early stage biotech company incorporated in late 2018, and located in Norfolk, Virginia. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.

Companies interested in meeting with ReAlta at BIO-Europe are asked to request a meeting through the event’s partneringONE^® online system or to contact Tom Filipczak at tfilipczak@destumpartners.com.